8-K
Current Report
Regen BioPharma Inc Filed Acc 0001607062-20-000023
Agreement ended · Executive or director change
- Item 1.02 Termination of a material definitive agreement
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading rgbp012220form8k.htm…